Inovio Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. It…

Biotechnology
US, Plymouth Meeting [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Inovio Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of INO's Analysis
CIK: 1055726 CUSIP: 45773H201 ISIN: US45773H4092 LEI: - UEI: -
Secondary Listings
INO has no secondary listings inside our databases.